United States Securities and Exchange Commission · EDGAR Accession 0001859067-26-000003

Form C

Offering Statement — Regulation Crowdfunding
Issuer CIK 1859067
Raising via Wefunder Portal LLC

Rejuvenate Bio, Inc.

CorporationDEIncorporated 2015San Diego, CArejuvenatebio.com
A

The Offering

as disclosed in this filing
Preferred Stock
$0.91
$50,000
$500,000
April 30, 2027
320 days remaining
$0max $500,000

Target is 10% of the maximum. Over-subscriptions accepted.

B

Financial Condition

two fiscal years, as filed
Burn decreasingDebt / assets 678%2 employees
Line itemMost recent FYPrior FYΔ
Revenue2,535,6570
Cost of goods sold2,257,925218,824▲ 932%
Net income(1,837,486)(2,930,382)▲ burn
Total assets1,988,4962,134,379▼ 7%
Cash & equivalents2,95470,701▼ 96%
Accounts receivable288,547335,348▼ 14%
Short-term debt8,985,9248,094,966▲ 11%
Long-term debt4,487,7345,383,366▼ 17%
Taxes paid00

Figures in USD as reported by the issuer. Securities offered in all 50 states.